Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Javier Martinez-Martin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drugs in Context|January 19, 2018
Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetesMargarita SaizSatjes, Francisco Javier Martinez-Martin
Expert Review of Cardiovascular Therapy|November 21, 2008
Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA studyFrancisco Javier Martinez-Martin, Margarita Saiz-Satjes
Future Cardiology|November 26, 2016
Factors associated with the reduction of albumin excretion in diabetic hypertensive patients: differential effect of manidipine versus amlodipineMargarita Saiz-Satjes, Francisco Javier Martinez-Martin, Alex Roca-Cusachs
Cureus|February 27, 2016
Complete Remission in Metastatic Pheochromocytoma Treated with Extensive SurgeryClaudia Arnas-Leon, Víctor Sánchez, Ana D Santana Suárez, et al.
Cardiology Journal|May 13, 2025
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024Krzysztof J Filipiak, Matteo Cameli, Santiago J Freire, et al.
Cardiology Journal|November 21, 2023
STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practiceKrzysztof J Filipiak, Vivencio Barrios, Claudio Ferri, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2022
Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapyFrancisco Javier Martinez-Martin, Agnieszka Kuzior, Alba Hernandez-Lazaro, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drugs in Context|January 19, 2018
Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetesMargarita SaizSatjes, Francisco Javier Martinez-Martin
Expert Review of Cardiovascular Therapy|November 21, 2008
Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA studyFrancisco Javier Martinez-Martin, Margarita Saiz-Satjes
Future Cardiology|November 26, 2016
Factors associated with the reduction of albumin excretion in diabetic hypertensive patients: differential effect of manidipine versus amlodipineMargarita Saiz-Satjes, Francisco Javier Martinez-Martin, Alex Roca-Cusachs
Cureus|February 27, 2016
Complete Remission in Metastatic Pheochromocytoma Treated with Extensive SurgeryClaudia Arnas-Leon, Víctor Sánchez, Ana D Santana Suárez, et al.
Cardiology Journal|May 13, 2025
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024Krzysztof J Filipiak, Matteo Cameli, Santiago J Freire, et al.
Cardiology Journal|November 21, 2023
STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practiceKrzysztof J Filipiak, Vivencio Barrios, Claudio Ferri, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2022
Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapyFrancisco Javier Martinez-Martin, Agnieszka Kuzior, Alba Hernandez-Lazaro, et al.
Pageof 1